# Cadence

> Cadence is a New York-based health technology company founded in 2020 that specializes in remote patient monitoring (RPM) and chronic disease management.

---
Type: post
Date: 2026-01-03
Reading time: 18 min read
Tags: competitor-analysis, healthcare
---

# Cadence - Comprehensive Research Report

*Research Completed: 2026-01-03*
*Research Depth: Comprehensive*

---

## Executive Summary

Cadence is a New York-based health technology company founded in 2020 that specializes in remote patient monitoring (RPM) and chronic disease management. The company provides an AI-powered remote care platform that enables healthcare systems to monitor patients with chronic conditions such as heart failure, hypertension, and type 2 diabetes outside of traditional clinical settings. Cadence reached a $1 billion valuation in December 2021 after raising $100 million in Series B funding, just months after emerging from stealth mode. The company has grown rapidly, partnering with 21 health systems across 33 states and serving over 74,000 patients as of December 2025.

**Key Facts at a Glance:**

| Attribute | Value |
|-----------|-------|
| **Founded** | 2020 |
| **Headquarters** | 295 Lafayette St, 7th Floor, New York, NY 10012 |
| **Stage** | Series B |
| **Total Funding** | $141M |
| **Last Round** | Series B - $100M (December 2021) |
| **Employees** | ~440 [Medium confidence: Apollo estimate [Accessed 2026-01-03](https://www.apollo.io)] |
| **Valuation** | $1B (post-Series B, December 2021) |
| **Patients Served** | 74,000+ active; 111,000+ lifetime |

---

## 1. Company Overview

### Basic Information

**Legal Name**: Cadence Solutions, Inc. [Accessed 2026-01-03](https://www.cadence.care/)
**Website**: https://www.cadence.care/
**Founded**: 2020 [2021-08-05](https://www.lifepointhealth.net/white-papers/introducing-cadence-a-new-health-tech-company-redefining-remote-care-for-the-nation's-largest-health-systems)
**Headquarters**: 295 Lafayette St, 7th Floor, New York, NY 10012 [Accessed 2026-01-03](https://www.cadence.care/)
**Company Type**: Private
**Company Stage**: Series B (Growth Stage)
**LinkedIn**: https://www.linkedin.com/company/cadencerpm [Accessed 2026-01-03](https://www.linkedin.com/company/cadencerpm)

### Mission & Vision

**Mission**: To provide life-changing care to one million people with chronic conditions by the end of the decade [2024-12-12](https://www.cadence.care/outcomes-report-2024)

**Vision**: To ensure every chronic disease patient has access to world-class care, with 24/7 support, cellular-enabled devices, and seamless communication with their care team [2024-12-12](https://www.cadence.care/outcomes-report-2024)

### Company Description

Cadence is a remote care delivery system that operates as an extension of physicians' offices and hospitals, utilizing an AI-powered "Proactive Care Engine" combined with a multidisciplinary clinical care team to monitor patients continuously. The company's platform collects and analyzes patients' vitals, medical history, and wellness data using machine learning to deliver personalized care.

The company was founded by Chris Altchek and Kareem Zaki (General Partner at Thrive Capital) with the vision of redefining chronic disease management through technology-enabled remote care. Cadence emerged from stealth mode in August 2021 with a partnership with LifePoint Health and rapidly scaled to unicorn status within four months of launch [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m).

Cadence's model shifts the focus from simply tracking symptoms to active remote care, ensuring patients with chronic conditions receive comprehensive support when and where they need it. The company emphasizes its role in "Remote Patient Care" (RPC) rather than just remote patient monitoring, highlighting the proactive clinical intervention aspect of their service [2024-12-12](https://www.cadence.care/outcomes-report-2024).

The team comprises clinical leaders, technologists, and healthcare entrepreneurs from institutions including Cleveland Clinic, Mass General, Duke Health, HCA, Landmark Health, Oscar, Cedar, Apple, Salesforce, Uber, Facebook, General Catalyst, and Thrive Capital [Accessed 2026-01-03](https://www.cadence.care/).

---

## 2. Financial Profile

### Funding Summary

**Total Funding Raised**: $141M [High confidence: [Accessed 2026-01-03](https://www.apollo.io), [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m)]
**Number of Rounds**: 2
**Most Recent Round**: Series B - $100M (December 2021)
**Most Recent Valuation**: $1B (post-money, December 2021) [High confidence: [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m)]

### Complete Funding History

| Round | Amount | Date | Lead Investor | Other Investors | Valuation | Source |
|-------|--------|------|---------------|-----------------|-----------|--------|
| Series B | $100M | December 2021 | Coatue Management | General Catalyst, Thrive Capital | $1B | [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m) |
| Seed/Series A | $41M | August 2021 | General Catalyst, Thrive Capital | Martin Ventures, Adam Boehler, Chelsea Clinton | Not disclosed | [2021-08-05](https://www.lifepointhealth.net/white-papers/introducing-cadence-a-new-health-tech-company-redefining-remote-care-for-the-nation's-largest-health-systems) |

### Detailed Round Information

**Series B**: $100M (December 2021)
- Lead Investor: Coatue Management [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m)
- Participating Investors: General Catalyst, Thrive Capital [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m)
- Valuation: $1B post-money [High confidence: [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m)]
- Timeline: Raised just 4 months after emerging from stealth mode
- Announcement: [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m)

**Seed/Venture Round**: $41M (August 2021)
- Lead Investors: General Catalyst, Thrive Capital [2021-08-05](https://www.lifepointhealth.net/white-papers/introducing-cadence-a-new-health-tech-company-redefining-remote-care-for-the-nation's-largest-health-systems)
- Other Investors: Martin Ventures, Adam Boehler (former Director of Center for Medicare and Medicaid Innovation), Chelsea Clinton [2021-08-10](https://www.instagram.com/p/CSaARbzlf7s/)
- Valuation: Not disclosed
- Use of Funds: Platform development and clinical team expansion

### Complete Investor List

- **Coatue Management**: Series B (Lead)
- **General Catalyst**: Seed, Series B
- **Thrive Capital**: Seed, Series B (Kareem Zaki serves on board)
- **Martin Ventures**: Seed
- **Adam Boehler**: Seed (Individual investor, former CMS Innovation Center Director)
- **Chelsea Clinton**: Seed (Individual investor)
- **Josh Kushner**: Via Thrive Capital

### Revenue & Financial Metrics

**Annual Revenue**: ~$2M [Low confidence: Apollo estimate [Accessed 2026-01-03](https://www.apollo.io) - Note: This appears to be an outdated estimate given the company's scale and growth]

**Revenue Model**: B2B SaaS + Clinical Services
- Health system partnerships with implementation fees
- Per-patient monitoring fees
- Medicare reimbursement for RPM/CCM services (CPT codes 99453, 99454, 99457, 99458)
- Chronic Care Management (CCM) services added in 2024 [2024-12-12](https://www.cadence.care/outcomes-report-2024)

**Financial Impact Claims**:
- Company claims [2024-12-12](https://www.cadence.care/outcomes-report-2024) over $150 per hypertension patient per month in savings
- Company claims [2024-12-12](https://www.cadence.care/outcomes-report-2024) over $1,000 per congestive heart failure patient per month savings
- Mayo Clinic Proceedings study showed $1,302 annual savings per patient [2025-11](https://www.cadence.care/post/cadence-announces-intended-participation-in-access-model-as-cms-advances-outcomes-based-chronic-disease-care)

---

## 3. Product & Technology

### Product Overview

Cadence provides a comprehensive Remote Patient Care (RPC) platform that combines AI-powered technology with clinician-led care for chronic disease management. The platform goes beyond traditional remote patient monitoring by providing active clinical intervention and care coordination.

### Product Portfolio

| Product | Description | Target Segment | Pricing Model |
|---------|-------------|----------------|---------------|
| Remote Patient Care (RPC) Platform | Core monitoring and care delivery platform for chronic conditions | Health Systems, Hospitals | B2B Partnership |
| Heart Failure Management Program | Specialized program for HF patients with GDMT optimization | Cardiology Departments | Per-patient fee |
| Hypertension Management Program | Blood pressure monitoring and medication management | Primary Care | Per-patient fee |
| Diabetes Management Program | Blood glucose monitoring and lifestyle coaching | Primary Care, Endocrinology | Per-patient fee |
| Chronic Care Management (CCM) | Comprehensive care coordination services (launched 2024) | Medicare Beneficiaries | Medicare reimbursement |
| Advanced Primary Care Management (APCM) | New CMS pathway service (launched 2025) | Primary Care | Medicare reimbursement |
| AHA Connected Care | Partnership program for post-discharge heart failure care | Hospitals, Health Systems | Partnership model |

### Core Capabilities

- **AI-Powered Proactive Care Engine**: Machine learning system that analyzes patient vitals, medical history, and wellness data to identify care gaps and predict deterioration [Accessed 2026-01-03](https://www.cadence.care/)
- **24/7 Clinical Care Team**: NP-led multidisciplinary team including medical directors, nurse practitioners, registered nurses, and medical assistants [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Cellular-enabled medical devices**: Next-generation devices compatible with Verizon, AT&T, T-Mobile, and US Cellular networks [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **EHR Integration**: Integrated with all major electronic medical records systems [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Medication Management & Titration**: Ability to adjust medications based on remote monitoring data [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Guideline-Directed Medical Therapy (GDMT) Optimization**: Protocols to increase adherence to evidence-based heart failure treatments [2024-12-12](https://www.cadence.care/outcomes-report-2024)

### Technology Approach

**Architecture**: Cloud-based platform with cellular connectivity for patient devices [Medium confidence: inferred from technology stack]

**Tech Stack** [Accessed 2026-01-03](https://www.apollo.io):
- Cloud: Amazon AWS
- CRM: Salesforce
- Analytics: Google Analytics, Google Tag Manager
- CMS: Webflow, WordPress
- Recruitment: Greenhouse.io
- Marketing: LinkedIn Marketing Solutions
- AI/ML: Proprietary algorithms for care gap detection

**Key Technical Differentiators** (Company claims):
- Device-agnostic platform that can expand across chronic disease programs [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- Cellular-enabled devices requiring no Wi-Fi setup [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- Real-time alert management with 99.5% resolution rate without physician involvement [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)

### Integrations & Platform

**EHR Integrations**: All major electronic medical record systems [2024-12-12](https://www.cadence.care/outcomes-report-2024)

**Device Compatibility**: Cellular-enabled blood pressure monitors, glucose monitors, weight scales, and pulse oximeters compatible with major US carriers [2024-12-12](https://www.cadence.care/outcomes-report-2024)

---

## 4. Leadership & Team

### Executive Team

| Role | Name | Background | Tenure | Source |
|------|------|------------|--------|--------|
| CEO & Founder | Chris Altchek | Healthcare entrepreneur | Since founding (2020) | [Accessed 2026-01-03](https://www.linkedin.com/in/chrisaltchek) |
| Co-Founder (Board) | Kareem Zaki | General Partner, Thrive Capital; Co-founder of Cedar, Nava, Rightway | Since founding (2020) | [Accessed 2026-01-03](https://www.crunchbase.com/person/kareem-zaki) |
| Medical Director | Dr. Randy Curnow | Clinical leadership | Unknown | [2024-12-12](https://www.cadence.care/outcomes-report-2024) |

### Detailed Executive Profiles

**Chris Altchek** - Founder & Chief Executive Officer
- Background: Healthcare entrepreneur with vision for technology-enabled chronic care
- Notable: Testified before U.S. House Committee on Ways & Means in March 2024 on access to care in rural communities [2024-03-12](https://www.cadence.care/post/cadence-ceo-testifies-before-full-house-committee-on-ways-means-about-access-to-care-at-home-for-rural-and-underserved-communities)
- Recognition: Awarded "Top 5 Startup in the US" in October 2025 [2025-10-20](https://www.instagram.com/p/DQCkAMtjWB3/)
- Source: [Accessed 2026-01-03](https://www.linkedin.com/in/chrisaltchek)

**Kareem Zaki** - Co-Founder (Board Member)
- Background: General Partner at Thrive Capital; Co-founded Cedar (healthcare payments), Nava (healthcare navigation), and Rightway (pharmacy benefits)
- Previous: Private Equity Investor at Blackstone Group
- Education: Harvard University
- Philosophy: "We're not going to build outside the system. We're going to build in the system." [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- Source: [Accessed 2026-01-03](https://www.crunchbase.com/person/kareem-zaki)

**Dr. Randy Curnow** - Medical Director
- Role: Clinical leadership and care quality oversight
- Source: [2024-12-12](https://www.cadence.care/outcomes-report-2024)

### Board of Directors

| Name | Role | Affiliation | Source |
|------|------|-------------|--------|
| Kareem Zaki | Co-Founder, Board Member | Thrive Capital | [2021-08-05](https://www.lifepointhealth.net/white-papers/introducing-cadence-a-new-health-tech-company-redefining-remote-care-for-the-nation's-largest-health-systems) |
| [Additional board members] | Director | General Catalyst (presumed) | [Not confirmed] |

### Founders

| Name | Role | Background | Status | Source |
|------|------|------------|--------|--------|
| Chris Altchek | Co-Founder & CEO | Healthcare entrepreneur | Active | [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m) |
| Kareem Zaki | Co-Founder | General Partner, Thrive Capital | Active (Board) | [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m) |

### Team Size & Growth

**Current Employees**: ~440 [Medium confidence: Apollo estimate [Accessed 2026-01-03](https://www.apollo.io)]
**Locations**: New York, NY (HQ); Clinical team distributed across US [Accessed 2026-01-03](https://www.cadence.care/)
**Clinicians**: Company stated expectation of 155 clinicians by mid-2022 [2021-12-14](https://pharmaphorum.com/news/remote-care-specialist-cadence-worth-1bn-after-raising-100m)

### Clinical Advisors & Partners

- **Dr. Marat Fudim**: Advanced Heart Failure Specialist, Cardiologist, Duke Health [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Dr. Eve Cunningham**: Chief of Virtual Care and Digital Health, Providence [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Dr. Chris Frost**: Senior Vice President, Chief Medical Officer and Chief Quality Officer, Lifepoint Health [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Dr. Mark Carvalho**: CEO, Montage Medical Group [2024-12-12](https://www.cadence.care/outcomes-report-2024)

---

## 5. Customers & Market

### Target Market

**Primary Segment**: Health Systems, Hospitals, Large Medical Groups [Accessed 2026-01-03](https://www.cadence.care/)
**Industry Verticals**: Healthcare - specifically organizations serving Medicare beneficiaries with chronic conditions
**Geographic Focus**: United States, with emphasis on rural and underserved communities [2024-12-12](https://www.cadence.care/outcomes-report-2024)
**Ideal Customer Profile**: Health systems seeking to improve chronic disease management, reduce hospital readmissions, and generate Medicare RPM/CCM revenue

### Customer Base

**Total Patients**: 74,000+ active patients; 111,000+ lifetime patients served [High confidence: [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)]
**Health System Partners**: 21 health systems across 33 states [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)
**Providers Using Platform**: 3,200+ primary care providers and cardiologists [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)

### Named Customers / Health System Partners

| Customer | Industry | Type | Source | Date Verified |
|----------|----------|------|--------|---------------|
| LifePoint Health | Health System (Rural-focused) | Multi-year partnership | [2021-08-05](https://www.lifepointhealth.net/white-papers/introducing-cadence-a-new-health-tech-company-redefining-remote-care-for-the-nation's-largest-health-systems) | 2021-08-05 |
| Providence | Large Health System | Partnership | [2024-10-10](https://ahahealthtech.org/panelists/chris-altchek/) | 2024-10-10 |
| RUSH | Health System | Partnership | [2024-10-10](https://ahahealthtech.org/panelists/chris-altchek/) | 2024-10-10 |
| BayCare | Health System | Partnership | [2024-10-10](https://ahahealthtech.org/panelists/chris-altchek/) | 2024-10-10 |
| Community Health Systems (CHS) | Large Health System | Partnership | [2024-10-10](https://ahahealthtech.org/panelists/chris-altchek/), [Accessed 2026-01-03](https://www.cadence.care/) | 2024-10-10 |
| Ardent Health | Health System | Partnership | [2024-10-10](https://ahahealthtech.org/panelists/chris-altchek/), [2024-08-19](https://hospitalogy.com/articles/2024-08-19/ardent-health-ipo-s1-breakdown/) | 2024-08-19 |
| FryeCare Generation (Lifepoint) | Medical Group | Partnership | [Accessed 2026-01-03](https://www.cadence.care/) | 2026-01-03 |
| South Baldwin Medical Group (CHS) | Medical Group | Partnership | [Accessed 2026-01-03](https://www.cadence.care/) | 2026-01-03 |
| Montage Medical Group | Medical Group | Partnership | [2024-12-12](https://www.cadence.care/outcomes-report-2024) | 2024-12-12 |

### Strategic Partnerships

**American Heart Association (AHA)**:
- Partnership: "AHA Connected Care, Powered by Cadence" program
- Focus: Post-discharge support for heart failure patients
- Results: 88% activation rates within 14 days of discharge [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)
- Announcement: [2025-08-26](https://newsroom.heart.org/news/novel-virtual-care-program-enhances-at-home-support-for-people-with-heart-failure)

### Customer Metrics (as reported by company)

- **Patient Satisfaction**: 4.9 out of 5 (based on 13,368 patient survey responses) [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Patient Engagement**: 84% of enrolled patients take vitals 16+ days per month; active patients average 22 days per month [Accessed 2026-01-03](https://www.cadence.care/)
- **Virtual Check-in Attendance**: 87% [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)
- **Patient Retention**: 62% of patients engaged for at least 12 months [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)
- **Rural/Underserved**: 60-63% of patients live in rural or underserved areas [2024-12-12](https://www.cadence.care/outcomes-report-2024)

---

## 6. Business Model & Go-to-Market

### Revenue Model

**Primary Revenue Streams**:
1. **Health System Partnerships**: Implementation and ongoing platform fees
2. **Per-Patient Monitoring Fees**: Recurring revenue per enrolled patient
3. **Medicare Reimbursement**: Revenue from CPT codes for RPM (99453, 99454, 99457, 99458) and CCM services
4. **Advanced Primary Care Management (APCM)**: New CMS billing pathway launched 2025 [2025-07-01](https://www.fiercehealthcare.com/digital-health/cadence-launches-advanced-primary-care-management-business-under-new-cms-pathway)

**Pricing Model**: B2B partnership model with health systems; per-patient economics [Company does not publicly disclose specific pricing]

### Go-to-Market Strategy

**Sales Model**: Enterprise B2B sales to health systems and large medical groups
- Direct sales to C-suite (CEOs, CMOs, Chief Digital/Virtual Care Officers)
- Clinical champion development within partner organizations
- Evidence-based selling with peer-reviewed research

**Marketing Approach**:
- Thought leadership through peer-reviewed publications
- Conference presentations (AHA Scientific Sessions, American Journal of Medicine)
- Government relations and policy advocacy (Congressional testimony)
- Outcomes reports and case studies

### Partnerships & Channels

**Strategic Partners**:
- American Heart Association (AHA Connected Care program) [2025-08-26](https://newsroom.heart.org/news/novel-virtual-care-program-enhances-at-home-support-for-people-with-heart-failure)
- Alliance for Connected Care (member) [Accessed 2026-01-03](https://connectwithcare.org/)

**Health System Partners**: 21 health systems including LifePoint, Providence, RUSH, BayCare, CHS, Ardent [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)

**Policy/Advocacy**: Active engagement with CMS, Congressional testimony on rural healthcare access [2024-03-12](https://www.cadence.care/post/cadence-ceo-testifies-before-full-house-committee-on-ways-means-about-access-to-care-at-home-for-rural-and-underserved-communities)

---

## 7. Competitive Context

### Company-Stated Positioning

Cadence positions itself as a "Remote Patient Care" company rather than a simple "Remote Patient Monitoring" vendor, emphasizing the clinical intervention and care team component as differentiation [2024-12-12](https://www.cadence.care/outcomes-report-2024)

### Third-Party Competitive Placement

**Peterson Health Technology Institute (PHTI) Assessment** [2024-10-28](https://phti.org/announcement/new-report-highlights-digital-solutions-that-improve-hypertension-control/):
- Cadence categorized in "Medication Management" approach alongside Ochsner Digital Medicine and Story Health
- PHTI found medication management approaches produce "meaningful improvements in systolic blood pressure more swiftly and effectively than traditional methods"
- Recognized as worthy of "broader adoption due to clinical benefits, potential long-term savings, and improvements to population health"

**Market Category**: Digital Chronic Disease Management / Remote Patient Monitoring + Clinical Services

**Competitors by Category**:

| Category | Competitors | Notes |
|----------|-------------|-------|
| Medication Management RPM | Ochsner Digital Medicine, Story Health | Same PHTI category as Cadence |
| Digital Chronic Care | Livongo (Teladoc), Omada Health | Focus on behavior change |
| RPM Platforms | HealthSnap, Athelas, Biofourmis | Device + platform focused |
| Hospital at Home | Contessa (Amedisys), Medically Home | Adjacent market |
| Virtual Primary Care | Teladoc, Amazon One Medical | Broader virtual care |

### Stated Differentiators (Company claims)

1. **NP-led Clinical Care Team**: Full clinical team vs. technology-only solutions [2024-12-12](https://www.cadence.care/outcomes-report-2024)
2. **Guideline-Directed Therapy Focus**: Emphasis on GDMT optimization for heart failure [2024-12-12](https://www.cadence.care/outcomes-report-2024)
3. **Peer-Reviewed Evidence Base**: Published in JACC, Mayo Clinic Proceedings, NEJM Catalyst, AHA Circulation [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)
4. **Rural/Underserved Focus**: 60%+ of patients in rural or underserved communities [2024-12-12](https://www.cadence.care/outcomes-report-2024)
5. **Device-Agnostic Cellular Platform**: No Wi-Fi required; works with major carriers [2024-12-12](https://www.cadence.care/outcomes-report-2024)
6. **Health System Partnership Model**: Embedded within existing care workflows vs. direct-to-consumer [2024-12-12](https://www.cadence.care/outcomes-report-2024)

### Recognition

- **LinkedIn Top 50 Startups**: Ranked #33 in 2024; only remote monitoring company on list [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **PHTI Recognition**: Medication Management approach recognized for clinical benefits and cost savings [2024-10-28](https://phti.org/announcement/new-report-highlights-digital-solutions-that-improve-hypertension-control/)

---

## 8. Recent Activity (Last 24 Months)

### Timeline

| Date | Event | Details | Source |
|------|-------|---------|--------|
| Dec 2025 | Outcomes Report | Released 3rd annual report: 74,000 patients, 21 health systems, 33 states | [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care) |
| Dec 2025 | CMS ACCESS Model | Announced intent to participate in new Medicare chronic care model | [2025-12-04](https://www.cadence.care/post/cadence-announces-intended-participation-in-access-model-as-cms-advances-outcomes-based-chronic-disease-care) |
| Nov 2025 | Mayo Clinic Study | Published study showing $1,302 annual savings, 27% reduction in hospitalizations | [2025-11](https://www.cadence.care/post/cadence-announces-intended-participation-in-access-model-as-cms-advances-outcomes-based-chronic-disease-care) |
| Nov 2025 | AHA Scientific Sessions | Presented heart failure data: 18% fewer admissions, $183 monthly savings | [2025-11](https://www.cadence.care/post/cadence-announces-intended-participation-in-access-model-as-cms-advances-outcomes-based-chronic-disease-care) |
| Oct 2025 | NEJM Catalyst | Case study with Providence validating scalable care model | [2025-10-15](https://www.cadence.care/post/new-england-journal-of-medicine-catalyst-validates-cadences-model-as-a-scalable-standard-of-care-for-management-of-chronic-disease) |
| Aug 2025 | AHA Connected Care Launch | Launched American Heart Association Connected Care partnership for heart failure | [2025-08-26](https://newsroom.heart.org/news/novel-virtual-care-program-enhances-at-home-support-for-people-with-heart-failure) |
| Jul 2025 | APCM Launch | Launched Advanced Primary Care Management business under new CMS pathway | [2025-07-01](https://www.fiercehealthcare.com/digital-health/cadence-launches-advanced-primary-care-management-business-under-new-cms-pathway) |
| Jul 2025 | JACC Publication | Hypertension study showing 70% improvement in BP control | [2025-07-23](https://www.jacc.org/doi/10.1016/j.jacadv.2025.101892) |
| Dec 2024 | 2024 Outcomes Report | Released annual report; PHTI recognition for medication management | [2024-12-12](https://www.cadence.care/post/cadences-2024-outcomes-report-a-new-era-in-primary-care) |
| Oct 2024 | PHTI Report | Recognized in Peterson Health Technology Institute digital hypertension assessment | [2024-10-28](https://phti.org/announcement/new-report-highlights-digital-solutions-that-improve-hypertension-control/) |
| Sep 2024 | Lifepoint Results | Published data showing rural patients matching/exceeding urban outcomes | [2024-09-11](https://www.fiercehealthcare.com/digital-health/cadence-and-lifepoint-rural-patients-surpass-urban-outcomes-through-rpm) |
| Apr 2024 | JACC Diabetes Study | Published study showing 43% of patients reached blood glucose goal | [2024-04](https://www.cadence.care/post/cadence-announces-intended-participation-in-access-model-as-cms-advances-outcomes-based-chronic-disease-care) |
| Mar 2024 | Congressional Testimony | CEO testified before House Ways & Means Committee on rural care access | [2024-03-12](https://www.cadence.care/post/cadence-ceo-testifies-before-full-house-committee-on-ways-means-about-access-to-care-at-home-for-rural-and-underserved-communities) |

### Key Research Publications

1. **JACC: Advances (July 2025)**: Hypertension study showing 70% improvement in patients meeting BP target [2025-07-23](https://www.jacc.org/doi/10.1016/j.jacadv.2025.101892)
2. **Mayo Clinic Proceedings (November 2025)**: $1,302 annual savings per patient, 27% reduction in hospitalizations [2025-11](https://www.cadence.care/post/cadence-announces-intended-participation-in-access-model-as-cms-advances-outcomes-based-chronic-disease-care)
3. **NEJM Catalyst (October 2025)**: Providence case study validating scalable model [2025-10-15](https://www.cadence.care/post/new-england-journal-of-medicine-catalyst-validates-cadences-model-as-a-scalable-standard-of-care-for-management-of-chronic-disease)
4. **AHA Circulation**: Remote patient monitoring service utilization patterns [2025-08-26](https://newsroom.heart.org/news/novel-virtual-care-program-enhances-at-home-support-for-people-with-heart-failure)
5. **Journal of Cardiac Failure (2024)**: Heart failure GDMT study [2024-12-12](https://www.cadence.care/outcomes-report-2024)

### Product Launches

- **Chronic Care Management (CCM)**: Launched 2024 - comprehensive care coordination services [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- **Advanced Primary Care Management (APCM)**: Launched July 2025 under new CMS billing pathway [2025-07-01](https://www.fiercehealthcare.com/digital-health/cadence-launches-advanced-primary-care-management-business-under-new-cms-pathway)
- **AHA Connected Care**: Launched August 2025 in partnership with American Heart Association [2025-08-26](https://newsroom.heart.org/news/novel-virtual-care-program-enhances-at-home-support-for-people-with-heart-failure)
- **Impact Calculator**: Tool for health systems to estimate capacity gains [2025-12-10](https://www.cadence.care/post/cadence-releases-third-annual-outcomes-report-the-shift-to-proactive-senior-care)

---

## 9. Online Presence & Brand

### Social Media

| Platform | Handle | Followers | Last Active | Source |
|----------|--------|-----------|-------------|--------|
| LinkedIn | /company/cadencerpm | Unknown | Active | [Accessed 2026-01-03](https://www.linkedin.com/company/cadencerpm) |
| Twitter/X | @cadencerpm | N/A (Suspended) | N/A | [Accessed 2026-01-03] |

### Digital Footprint

**Website**: https://www.cadence.care/ - Active with patient portal, provider information, outcomes reports
**Content Marketing**: Annual Outcomes Reports, peer-reviewed publications, blog posts
**Thought Leadership**: Congressional testimony, conference presentations, podcast appearances

### Reputation Metrics

**Patient Satisfaction**: 4.9 out of 5 (company-reported, based on 13,368 survey responses) [2024-12-12](https://www.cadence.care/outcomes-report-2024)

**Industry Recognition**:
- LinkedIn Top 50 Startups #33 (2024) [2024-12-12](https://www.cadence.care/outcomes-report-2024)
- PHTI "broader adoption" recommendation (2024) [2024-10-28](https://phti.org/announcement/new-report-highlights-digital-solutions-that-improve-hypertension-control/)

---

## 10. Risk Factors & Concerns

### Documented Concerns

**Regulatory/Reimbursement Risk**:
- Company's business model heavily dependent on Medicare RPM/CCM reimbursement rates
- CEO testified to Congress about geographic adjustments in Medicare payment that "disincentivize RPM adoption in rural and underserved areas" [2024-03-12](https://www.cadence.care/post/cadence-ceo-testifies-before-full-house-committee-on-ways-means-about-access-to-care-at-home-for-rural-and-underserved-communities)
- Pandemic telehealth flexibilities expiring; future of home-based care models uncertain [2024-03-12](https://www.cadence.care/post/cadence-ceo-testifies-before-full-house-committee-on-ways-means-about-access-to-care-at-home-for-rural-and-underserved-communities)

**Market/Competitive Risk**:
- Crowded RPM market with well-funded competitors
- Large health systems may build internal capabilities
- Teladoc/Livongo, Omada, and others competing in adjacent spaces

**Funding Gap**:
- No disclosed funding since Series B in December 2021 (4+ years ago)
- Status of fundraising efforts unknown [Not Available]

**Financial Transparency**:
- Private company with limited financial disclosure
- Revenue estimates vary significantly ($2M Apollo estimate appears outdated given scale)

### No Significant Operational Concerns Found

- No reported layoffs in recent news
- No executive departures noted
- No negative press coverage identified
- No regulatory investigations disclosed

---

## 11. Research Methodology & Limitations

### Sources Used

**Primary Sources**:
- Company website (cadence.care) - Accessed 2026-01-03
- Company press releases and blog posts
- Congressional testimony transcript

**Secondary Sources**:
- Pharmaphorum funding announcement (December 2021)
- Fierce Healthcare articles (2024-2025)
- LifePoint Health press release (August 2021)
- Apollo.io company enrichment data
- Google Search results
- Peterson Health Technology Institute report (October 2024)

**Academic/Research Sources**:
- JACC: Advances (July 2025)
- Mayo Clinic Proceedings (November 2025)
- NEJM Catalyst (October 2025)
- Journal of Cardiac Failure (2024)

### Research Limitations

**Data Gaps**:
- Detailed revenue figures not publicly disclosed
- Complete board composition not confirmed
- Full executive team details limited
- Specific pricing/contract terms not available
- No recent funding information (last round December 2021)

**Confidence Notes**:
- Employee count (~440) from Apollo estimate - Medium confidence
- Revenue estimate ($2M) appears significantly outdated given company scale
- Clinical outcomes data primarily from company-sponsored/published research

**Temporal Limitations**:
- Research current as of January 3, 2026
- Funding information dated (last round 4+ years ago)
- Some operational metrics from 2024 outcomes report

### Data Quality Summary

| Category | Completeness | Confidence |
|----------|--------------|------------|
| Basic Info | High | High |
| Funding | High | High |
| Product | High | High |
| Leadership | Medium | Medium |
| Customers | High | High |
| Financials | Low | Low |
| Recent Activity | High | High |
| Competitive | Medium | Medium |

---

## 12. Tags

`healthcare` `remote-patient-monitoring` `chronic-care-management` `digital-health` `series-b` `unicorn` `enterprise-sales` `ai-powered` `medicare` `b2b` `saas` `clinical-services` `heart-failure` `hypertension` `diabetes`

**Tag Categories**:
- **Customer Segment**: `enterprise` (health systems)
- **Product Approach**: `platform` + `clinical-services` / `vertical-healthcare`
- **Stage**: `growth-stage` (Series B, $1B valuation)
- **Business Model**: `saas` + `clinical-services` / `enterprise-sales`
- **Technology**: `ai-powered` / `cloud-native` / `mobile-devices`
- **Geographic**: `us-only`
- **Industry**: `healthcare` / `digital-health` / `chronic-care`

---

*Research completed by Company Deep Researcher Agent*
*Date: 2026-01-03*